BIEL Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: May 14, 2026
Report Source: 2024 Annual Report
BioElectronics Corp. Stock Analysis BIEL
BioElectronics Corp. engages in the development of wearable, nueromodulation devices for diabetic neuropathy, postoperative surgery, chronic wounds, and other applications. The company is headquartered in Frederick, Maryland. The company went IPO on 2004-04-12. Its pulsed shortwave therapy technology (PSWT) uses low-power pulsed electromagnetic fields to regulate electrical activity of the nervous system. The Company’s product line includes ActiPatch Musculoskeletal Pain Therapy, and RecoveryRx Post-operative and Chronic Wounds Therapy, which are sold by or on the order of medical professionals. PSWT is a non-invasive electromagnetic therapy designed to reduce pain and enhance life in patients with chronic musculoskeletal conditions. PSWT has no systemic side effects and can be self-administered at home. The ActiPatch product provides advanced long-lasting pain relief using Electromagnetic Pulse Therapy and works great for back pain, knee pain, muscle & joint pain, arthritis, sciatica, fibromyalgia, strains, sprains and more.
Read More BioElectronics Corp (BIEL) Chart
Key Statistics of BioElectronics Corp (BIEL)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.00Volume
5.03MP/E Ratio (TTM)
-52 Week Range
Market Cap
12.35MAvg. Volume
13.14MDividend Yield
-Financial Metrics & Statements of BioElectronics Corp (BIEL)
FAQ's for BioElectronics Corp (BIEL)
- According to Musaffa’s Shariah screening methodology, BioElectronics Corp (BIEL) is currently classified as NOT HALAL as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.